Corticotropin-Releasing Factor Receptor Neurons

Corticotropin-Releasing Factor Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Corticotropin-Releasing Factor Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuropeptide Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Hypothalamus, Amygdala, Hippocampus, Locus Coeruleus, Cortex</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>CRF-R1 (CRHR1), CRF-R2 (CRHR2)</td>
</tr>
<tr>
<td class="label">Ligands</td>
<td>CRF, Urocortin 1, 2, 3</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gs/Gq-coupled, increases cAMP and IP3</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Corticotropin Releasing Factor Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Corticotropin-Releasing Factor (CRF) and its receptors are central to stress response and have significant implications in neurodegenerative disease pathophysiology. [@holsboer1999]

Overview

Corticotropin-Releasing Factor Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Corticotropin-Releasing Factor Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuropeptide Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Hypothalamus, Amygdala, Hippocampus, Locus Coeruleus, Cortex</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>CRF-R1 (CRHR1), CRF-R2 (CRHR2)</td>
</tr>
<tr>
<td class="label">Ligands</td>
<td>CRF, Urocortin 1, 2, 3</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gs/Gq-coupled, increases cAMP and IP3</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Corticotropin Releasing Factor Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Corticotropin-Releasing Factor (CRF) and its receptors are central to stress response and have significant implications in neurodegenerative disease pathophysiology. [@holsboer1999]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: corticotropin-releasing neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Properties

CRF System

• Ligands: CRF (CRH), Urocortin 1 (UCN1), UCN2, UCN3
• Precursor: CRH gene
• Peptide length: 41 amino acids (CRF)
• Receptor types: CRF-R1, CRF-R2

Receptor Subtypes

CRF-R1

• Gene: CRHR1
• Distribution: Pituitary, cortex, hippocampus, amygdala
• Signaling: Gs → ↑ cAMP; Gq → ↑ IP3/Ca2+
• Affinity: CRF > UCN1 >> UCN2/3

CRF-R2

• Gene: CRHR2
• Distribution: Hypothalamus, hippocampus, peripheral tissues
• Signaling: Gs → ↑ cAMP
• Affinity: UCN1 > UCN2/3 > CRF

Distribution in Brain

• Paraventricular nucleus (PVN): CRF cell bodies
• Central amygdala: CRF interneurons
• Hippocampus: CA1, dentate gyrus
• Locus coeruleus: Noradrenergic modulation
• Prefrontal cortex: Stress-responsive neurons

Functions

Stress Response

• HPA axis activation: Drives ACTH/cortisol release
• Behavioral responses: Anxiety, fear, arousal
• Autonomic regulation: Heart rate, blood pressure
• Energy mobilization: Glucose, fatty acids

Cognitive Effects

• Memory consolidation: Under stress conditions
• Synaptic plasticity: Modulates LTPmechanisms/long-term-potentiation)/LTD
• Neurogenesis: Bidirectional effects

Neuroprotection vs. Neurotoxicity

• Acute stress: Adaptive, neuroprotective
• Chronic stress: Maladaptive, contributes to neurodegeneration
• Glucocorticoid mediation: Effects via GR activation

Clinical Significance in Neurodegeneration

Alzheimer's Disease

• HPA axis hyperactivity: Elevated cortisol in AD patients
• Amyloid interaction: CRF modulates Aβ processing
• Tau pathology: Stress exacerbates tau phosphorylation
• Cognitive impairment: Chronic cortisol impairs memory
• Neuronal loss: CRF-R1 activation may promote neuronal death
• Therapeutic targeting: CRF-R1 antagonists in development

Parkinson's Disease

• Stress exacerbation: Stress worsens motor symptoms
• Dopaminergic vulnerability: CRF-R1 may increase neuron susceptibility
• Alpha-synuclein: Stress accelerates aggregation
• Depression/anxiety: Non-motor symptoms linked to CRF
• L-DOPA-induced dyskinesia: CRF-R1 involvement

Other Neurodegenerative Conditions

• Huntington's Disease: Elevated CSF CRF, CRF-R1 changes
• Multiple System Atrophy: Dysregulated stress response
• Frontotemporal Dementia: Altered CRF signaling
• Stroke: CRF in ischemic injury

Therapeutic Implications

CRF-R1 Antagonists

• CP-154,526: Early research compound
• R121919: Human trials for depression
• Pexacerfont: Clinical development discontinued
• Verucerfont: CNS-penetrant antagonist

CRF-R2 Agonists

• UCN1: Neuroprotective peptide
• Stresscopin: Humanized analog

Clinical Applications

• Depression: CRF-R1 antagonists (limited efficacy)
• Anxiety disorders: Modulation of stress response
• Neurodegeneration: Potential disease modification

Research Methods

Genetic Models

• CRF knockout mice: Impaired stress response
• CRF-R1 conditional KO: Region-specific effects
• Transgenic AD models: CRF overexpression

Pharmacological Tools

• Radioligands: 125ITyr0-CRF for receptor binding
• Antisense oligonucleotides: Knockdown studies
• Viral vectors: Region-specific manipulation
• Hypothalamic Neurons
• Amygdala Neurons
• Hippocampal Neurons
• Stress Response Mechanisms)
• Alzheimer's Disease Mechanisms
• Parkinson's Disease Mechanisms

External Links

• [UniProt: CRF](https://www.uniprot.org/uniprot/P06881)
• [UniProt: CRF-R1](https://www.uniprot.org/uniprot/P35559)
• [IUPHAR: CRF receptors](https://www.guidetopharmacology.org/GRID/GRID17)
• [GeneCards: CRHR1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRHR1)

Background

The study of Corticotropin Releasing Factor Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Corticotropin-Releasing Factor Receptor Neurons discovered through SciDEX knowledge graph analysis: